Cancel
Known information
- Previously served as President from January 2013 to October 2019
- Previously served as Chief Medical Officer from October 2019 to February 2022
- Is an expert in prostate cancer research and treatment
- Has served as a Radiation Oncologist for several cancer centers
- Has served as an Adjunct Assistant Professor in Internal Medicine, Pathology, and Urology at the Texas Tech University Health Sciences Center
- Has patented, manufactured, and commercialized intellectual property
- Has more than a decade of experience in medical and oncology commerce
- Earned an MD from the University of Texas Health Science Center at Houston
- Completed residencies in family practice and radiation oncology
- Earned a PharmD degree from the University of Nebraska Medical Center, College of Pharmacy
About Kiromic BioPharma
Kiromic BioPharma, based in Houston, Texas, focuses on developing innovative cell therapies for cancer using its proprietary DIAMOND AI and ABBIE platforms to enhance target identification and improve manufacturing processes.
Report inaccurate information
